Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment
Authors
Keywords
-
Journal
Biomedicines
Volume 9, Issue 8, Pages 891
Publisher
MDPI AG
Online
2021-07-26
DOI
10.3390/biomedicines9080891
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
- (2021) Harshad Devarbhavi et al. Hepatology International
- Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
- (2020) Marlene Christina Nielsen et al. Cells
- EASL Clinical Practice Guidelines: Drug-induced liver injury
- (2019) Raúl Andrade et al. JOURNAL OF HEPATOLOGY
- Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury
- (2019) Zhongyang Xie et al. JOURNAL OF PROTEOME RESEARCH
- Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
- (2019) Gaby Danan et al. Frontiers in Pharmacology
- Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming of impaired regeneration pathways in mice
- (2019) Xiaogang Xiang et al. JOURNAL OF HEPATOLOGY
- Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
- (2019) Lucy Meunier et al. Frontiers in Pharmacology
- Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
- (2018) Conor Duncan Tweed et al. BMC Medicine
- Alcohol Use in Patients with Chronic Liver Disease
- (2018) Daniel Fuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- SP110 Polymorphisms Are Genetic Markers for Vulnerability to Latent and Active Tuberculosis Infection in Taiwan
- (2018) So-Yi Chang et al. DISEASE MARKERS
- Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
- (2017) Anders Etzerodt et al. Scientific Reports
- Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects
- (2016) Eunkyoung You et al. TUBERCULOSIS
- ImPortance of IP-10 in hepatitis B
- (2015) Markus Cornberg et al. ANTIVIRAL THERAPY
- RUCAM in Drug and Herb Induced Liver Injury: The Update
- (2015) Gaby Danan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CXCR3, CXCL10 and type 1 diabetes
- (2014) Alessandro Antonelli et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C
- (2014) Konstantin Kazankov et al. HEPATOLOGY
- Acute and Chronic Effects of IL-22 on Acetaminophen-Induced Liver Injury
- (2014) Dechun Feng et al. JOURNAL OF IMMUNOLOGY
- Nationwide Longitudinal Analysis of Acute Liver Failure in Taiwan
- (2014) Cheng-Maw Ho et al. MEDICINE
- Efficacy of IP-10 as a biomarker for monitoring tuberculosis treatment
- (2013) Ji Young Hong et al. JOURNAL OF INFECTION
- Interleukin 22 Inhibits Intracellular Growth of Mycobacterium tuberculosis by Enhancing Calgranulin A Expression
- (2013) Rohan Dhiman et al. JOURNAL OF INFECTIOUS DISEASES
- Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid
- (2013) J CJ Martin et al. Mucosal Immunology
- Profiles of Serum Cytokines in Acute Drug-Induced Liver Injury and Their Prognostic Significance
- (2013) Nury M. Steuerwald et al. PLoS One
- The Severity of Experimental Autoimmune Cystitis Can be Ameliorated by Anti-CXCL10 Ab Treatment
- (2013) Udai P. Singh et al. PLoS One
- Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis
- (2012) H. Grønbaek et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Soluble CD163 promotes recognition, phagocytosis and killing of Staphylococcus aureus via binding of specific fibronectin peptides
- (2012) Jessica Kneidl et al. CELLULAR MICROBIOLOGY
- Soluble CD163: a biomarker linking macrophages and insulin resistance
- (2012) T. Parkner et al. DIABETOLOGIA
- Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects
- (2011) Markella V. Zanni et al. CLINICAL ENDOCRINOLOGY
- Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
- (2011) Jann-Yuan Wang et al. JOURNAL OF INFECTION
- The potential of cytokines as safety biomarkers for drug-induced liver injury
- (2010) Hugh G. Laverty et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- IL-17 and IL-22: siblings, not twins
- (2010) Stefanie Eyerich et al. TRENDS IN IMMUNOLOGY
- Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis
- (2009) Jann-Yuan WANG et al. RESPIROLOGY
- IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia
- (2008) Shean J Aujla et al. NATURE MEDICINE
- Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
- (2008) Yan Zheng et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More